35 - Bungarotoxins
References (0)
Cited by (3)
Targeting the α7 nicotinic acetylcholine receptor—A novel road towards the future treatment of skin diseases
2020, Experimental Dermatology
- *
Dr. Kullman does not report any conflicts of interest. Dr. de Groat is disclosing that he has acted as a consultant for Allergen, Irvine, CA; Ethicon, Somerville, NJ; Procter and Gamble Pharmaceuticals, Mason, OH; Dynogen, Boston, MA; Puretech Ventures, Boston, MA; Hydra, Boston, MA; Medtronic, Minneapolis, MN. Dr. Artim does not report any conflicts of interest.
Copyright © 2009 Elsevier Inc. All rights reserved.